[1]刘艳霞,区静怡,黄 颖,等.新型冠状病毒肺炎患者外周血淋巴细胞及其亚群检测的临床意义[J].现代检验医学杂志,2020,35(04):94-96,105.[doi:10.3969/j.issn.1671-7414.2020.04.023]
 LIU Yan-xia,OU Jing-yi,HUANG Ying,et al.Clinical Significance of Detection of Peripheral Blood Lymphocyte and Its Subgroups in Patients with Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2020,35(04):94-96,105.[doi:10.3969/j.issn.1671-7414.2020.04.023]
点击复制

新型冠状病毒肺炎患者外周血淋巴细胞及其亚群检测的临床意义()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第35卷
期数:
2020年04期
页码:
94-96,105
栏目:
新型冠状病毒肺炎检验专题
出版日期:
2020-09-05

文章信息/Info

Title:
Clinical Significance of Detection of Peripheral Blood Lymphocyte and Its Subgroups in Patients with Coronavirus Disease 2019
文章编号:
1671-7414(2020)04-094-04
作者:
刘艳霞区静怡黄 颖陈 星陈意珊江鸿雅石亚玲
(广州市第八人民医院检验科,广州 510440)
Author(s):
LIU Yan-xia OU Jing-yi HUANG Ying CHEN Xing CHEN Yi-shan JIANG Hong-ya SHI Ya-ling
(Department of Clinical Laboratory, the Eighth People’s Hospital of Guangzhou City,Guangzhou 510440,China)
关键词:
淋巴细胞淋巴细胞亚群新型冠状病毒肺炎
分类号:
R373.1;R446.62
DOI:
10.3969/j.issn.1671-7414.2020.04.023
文献标志码:
A
摘要:
目的 探讨外周血淋巴细胞及其亚群在新型冠状病毒肺炎(COVID-19)患者中的应用价值。方法 选取2020 年2 月14 日~3 月11 日收治于广州市第八人民医院的216 例COVID-19 患者为研究对象,其中普通组194 例,重型组15 例,危重组7 例,检测各组的白细胞计数、淋巴细胞计数和淋巴细胞亚群计数并进行比较。结果 重型组、危重组的淋巴细胞计数、T 淋巴细胞计数、CD4+T 淋巴细胞计数、CD8+T 淋巴细胞计数和B 淋巴细胞计数低于普通组,差异具有统计学意义(Z =-12.114 ~ -3.376,P<0.05)。危重组的淋巴细胞计数、T 淋巴细胞计数、CD4+T 淋巴细胞计数和NK 细胞计数低于重型组,差异具有统计学意义(Z = -3.986 ~ -1.975,P <0.05)。结论 对COVID-19患者外周血淋巴细胞及淋巴细胞亚群进行分析,在反映COVID-19 患者机体免疫系统受损程度及评估病情方面具有一定的临床应用价值。

参考文献/References:

[1] 童伟,陈登奕,陈俊文,等.2019-nCoV 总抗体两种免疫学检测方法的应用评价[J]. 现代检验医学杂志, 2020, 35(2): 80-82. TONG Wei,CHEN Dengyi,CHEN Junwen,et al.Application evaluation of two immunological detectionmethods of 2019-nCoV specific antibodies[J].Journalof Modern Laboratory Medicine. 2020,35(2):80-82.
[2] 吕晓艳,肖贺欣,王言,等.儿童呼吸系统感染性疾病中淋巴细胞亚群的改变及临床价值[J].国际检验医学杂志, 2019, 40(18): 2177-2180, 2185. Lü Xiaoyan, XIAO Hexin, WANG Yan, et al. Changesand clinical value of lymphocyte subsets in children withrespiratory infectious diseases[J]. International Journal ofLaboratory Medicine, 2019,40(18):2177-2185.
[3] 赵晨旭,鲍文华,赵锦程,等.T 淋巴细胞亚群在呼吸系统疾病发生发展中作用的研究进展[J].中国医学创新, 2019, 16(20): 169-172. ZHAO Chenxu, BAO Wenhua, ZHAO Jincheng, etal. Research progress of T lymphocyte subsets in theoccurrence and development of respiratory diseases[J].Medical Innovation of China, 2019,16 (20):169-172.
[4] 中华人民共和国国家卫生健康委员会. 国卫办医函〔2020〕145 号: 关于印发新型冠状病毒肺炎诊疗方案(试行第六版)的通知[EB/OL]. (2020-02-19).http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2.shtml. National Health Commission of the People’s Republic ofChina .Medical Letter of the State Health Office [2020]No. 145:Notification on the issuance of COVID-19medical program (trial sixth edition) [EB/OL]. (2020-02-19) .http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
[5] 石亚玲, 区静怡, 陈星, 等. 多种炎症指标在新型冠状病毒肺炎的表达水平及临床应用价值[J] 中华检验医学杂志, 2020,43(4): 346-351. SHI Yaling, OU Jingyi, CHEN Xing, et al. Expressionsof multiple inflammation markers in the patients withCOVID-19 and their clinical values [J]. Chin J LabMed, 2020,43(4): 346-351.
[6] MANSON J,COLE E,DE’ATH H D,et al .Early changeswithin the lymphocyte population are associatedwith the development of multiple organ dysfunctionsyndrome in trauma patients[J]. Critical Care (London,England),2016,20(1): 176.
[7] 周玉平,朱传新,龚娇芳,等.新冠肺炎患者临床实验室检测结果分析[J]. 现代检验医学杂志,2020,35(2): 83-87. ZHOU Yuping,ZHU Chuanxin,GONG Jiaofang,et al. Analysis of clinical laboratory test results inpatients with novel coronavirus pneumonia[J].Journalof Modern Laboratory Medicine, 2020,35(2):83-87.
[8] 袁红瑛,王勇,张继学,等.成人病毒性肺炎患者肺泡灌洗液中T 细胞亚群检测的临床意义[J]. 中国现代医学杂志,2015, 25(7): 41-43. YUAN Hongying, WANG Yong, ZHANG Jixue, etal. Clinical significance of T cell subsets detectionof broncho alveolar lavage fluid in adult patientswith virus pneumonia[J]. China Journal of ModernMedicine , 2015,25 (7): 41-43.
[9] GUPTA K K, KHAN M A, SINGH S K. Constitutiveinflammatory cytokine storm: A major threat tohuman health [J]. Journal of Interferon & CytokineResearch,2020,40(1):19-23.
[10] DIAO Bo ,WANG Chenhui ,TAN Yingjun ,et al. Reductionand functional exhaustion of T cells in patientswith coronavirus disease 2019 (COVID-19)[J]. Frontiersin Immunology,2020,11:827.
[11] GIAMARELLOS-BOURBOULIS E J, TSAGANOST , SPYRIDAKI E, et al. Early changes of CD4-positivelymphocytes and NK cells in patients with severeGram-negative sepsis[J]. Critical care (London, England),2006,10(6)): R166.

相似文献/References:

[1]孟凡萍,郝 坡.新型冠状病毒肺炎患者外周血淋巴细胞亚群的分析研究[J].现代检验医学杂志,2021,36(02):114.[doi:doi:10.3969/j.issn.1671-7414.2021.02.027]
 MENG Fan-ping,HAO Po.Analysis of Peripheral Blood Lymphocyte Subsets in Patients with Novel Coronavirus Pneumonia[J].Journal of Modern Laboratory Medicine,2021,36(04):114.[doi:doi:10.3969/j.issn.1671-7414.2021.02.027]
[2]黄玉斌a,刘 霄a,徐翠香b,等.中晚期恶性肿瘤患者应用PD-1抑制剂多周期治疗对外周血淋巴细胞亚群影响的动态变化研究[J].现代检验医学杂志,2022,37(02):23.[doi:10.3969/j.issn.1671-7414.2022.02.005]
 HUANG Yu-bina,LIU Xiaoa,XU Cui-xiangb,et al.Study on the Dynamic Changes of the Effect of PD-1 Inhibitor Multi-cycle Therapy on Peripheral Blood Lymphocyte Subsets in Patients with Advanced Malignant Tumors[J].Journal of Modern Laboratory Medicine,2022,37(04):23.[doi:10.3969/j.issn.1671-7414.2022.02.005]
[3]李彬钰a,马锡慧a,李 蕊a,等.老年新型冠状病毒感染患者外周血淋巴细胞亚群和多种细胞因子水平分析及其临床价值研究[J].现代检验医学杂志,2024,39(02):113.[doi:10.3969/j.issn.1671-7414.2024.02.021]
 LI Binyua,MA Xihuia,LI Ruia,et al.Analysis and Clinical Value of Lymphocyte Subsets and Various Cytokines of Peripheral Blood in Elderly Patients with COVID-19[J].Journal of Modern Laboratory Medicine,2024,39(04):113.[doi:10.3969/j.issn.1671-7414.2024.02.021]

备注/Memo

备注/Memo:
收稿日期:2020-04-22修回日期:2020-05-22作者简介:刘艳霞(1987-),女,本科,检验技师,研究方向:医学检验,E-mail:987798630@qq.com。通讯作者:石亚玲,女,主任检验技师,研究方向:医学检验,E-mail: 13798066558@126.com。
更新日期/Last Update: 2020-10-08